Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

PURPOSE: To evaluate the potential of etanercept versus sulfasalazine to reduce active inflammatory lesions on whole-body MRI in active axial spondyloarthritis with a symptom duration of less than 5 years. METHODS: Patients were randomly assigned to etanercept (n=40) or sulfasalazine (n=36) treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, I-H, Hermann, KG, Haibel, H, Althoff, CE, Listing, J, Burmester, GR, Krause, A, Bohl-Bühler, M, Freundlich, B, Rudwaleit, M, Sieper, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211465/
https://www.ncbi.nlm.nih.gov/pubmed/21372193
http://dx.doi.org/10.1136/ard.2010.139667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211465/
https://www.ncbi.nlm.nih.gov/pubmed/21372193
http://dx.doi.org/10.1136/ard.2010.139667

Ejemplares similares